Drug-associated polymyalgia rheumatica/giant cell arteritis occurring in two patients after treatment with ipilimumab, an antagonist of ctla-4

Arthritis Rheumatol. 2014 Mar;66(3):768-9. doi: 10.1002/art.38282.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Giant Cell Arteritis / chemically induced*
  • Humans
  • Ipilimumab
  • Male
  • Melanoma / drug therapy
  • Middle Aged
  • Polymyalgia Rheumatica / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Ipilimumab

Associated data

  • ClinicalTrials.gov/NCT00556439